Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 9;2(1):vdaa085. doi: 10.1093/noajnl/vdaa085

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Kaplan–Meier analysis of DG_T1Gd using previously identified optimal DG_T1Gd cutoffs²⁴ in the complete cohort (first column, A–B) and subanalysis by treatment group (second and third columns, C–F) for OS and PFS. Prior cutoffs significantly discriminated survivor groups in the recurrent setting for OS and PFS. In further subanalysis by treatment, prior cutoffs significantly discriminated survivor groups for BevCyto patients (E–F), but not for BevAlone patients (C–D). High and Low DG groups were set based on the assigned cutoffs reported in Table 2.